Navigation Links
Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
Date:12/18/2013

DUBLIN, Dec. 18, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/mqs7t3/merger_and) has announced the addition of the "Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter merger and acquisition deals.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all merger and acquisition deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual merger and acquisition contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Key Topics Covered:

Executive Summary

1. Introduction

2. Trends in M&A dealmaking
2.1. Introduction
2.2. Difference between merger and acquisition deals
2.3. Trends in M&A deals since 2009
2.4. When M&A can be useful
2.5. Attributes of M&A deals
2.6. Partnering deals with M&A component
2.7. Bigpharma mega mergers - are we at the end of the road?
2.8. Accessing innovation through M&A
2.9. The emerging role of private equity in M&A
2.10. Implementing M&A transactions
2.11. Joint ventures as alternative to M&A
2.12. The future of M&A in biopharma

3. Overview of M&A deal structure
3.1. Introduction
3.2. Pure versus multi-component acquisition deals
3.3. Pure M&A agreement structure
3.4. Acquisition as part of a wider alliance agreement
3.5. Merger agreements

4. Leading M&A deals
4.1. Introduction
4.2. Top M&A deals by value
4.3. Top merger deals
4.4. Bigpharma M&A deal activity

5. Bigpharma M&A deals
5.1. Introduction
5.2. How to use M&A deals
5.3. Bigpharma company M&A deal profiles

6. M&A contracts directory
6.1. Introduction
6.2. Company A-Z
6.3. By industry sector

Companies Mentioned:

  • Abbott Japan
  • Bristol-Myers Squibb
  • Cytokinetics
  • Dyax
  • Exelixis
  • GlaxoSmithKline
  • Hyperion Therapeutics
  • Ironwood Pharmaceuticals
  • Janssen Research & Development
  • KaloBios Pharmaceuticals
  • La Jolla Pharmaceutical
  • Millennium
  • Nycomed
  • Ortho Biotech
  • Procter & Gamble Pharmaceuticals
  • Seattle Genetics
  • Serono
  • Sigma-Tau
  • Solvay
  • Somaxon Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Transcept Pharmaceuticals
  • Ucyclyd Pharma
  • Victory Pharma
  • Warner Chilcott
  • Watson Pharmaceuticals
  • Wyeth
  • Xenoport
  • Zogenix
  • ZymoGenetics

For more information visit http://www.researchandmarkets.com/research/mqs7t3/merger_and

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Spotlight Innovation, Inc. Announces Name Change and Closing of Merger
2. PharmAthene Announces Termination Of Merger Agreement With Theraclone Sciences
3. Steep Hill Laboratories and Halent Scientific Proudly Announce Historic Merger
4. 3SBio Inc. Announces Completion of Merger
5. 3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction
6. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
7. Epilepsy Foundation and Epilepsy Therapy Project Finalize Merger To Create Strong, Unified Organization To Support People with Epilepsy
8. Perrigo Company And Elan Corporation plc Receive Irish High Court Approval For Perrigos Proposed Acquisition Of Elan
9. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
10. Covington Advises Salix in $2.6 Billion Acquisition of Santarus
11. Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 On Thursday, February 11, ... for community, health and disaster services, and the ... to enhance care coordination and service delivery for the ... need and to better connect service providers to the ... San Diego has handled more than ...
(Date:2/5/2016)... drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ: ... Mr John O,Connor , and new Deputy Chairman, Mr ... Garner , has also been formally appointed to the Board ... Iain Ross , will resume his role on the Board ... has also been formally appointed to the Board as an ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... ... , ... Shimadzu Scientific Instruments will showcase several new products, ... sessions, and present on the analysis of mycotoxins and medical cannabis at the ... at the Georgia World Congress Center in Atlanta, Georgia. , Attendees should ...
Breaking Biology Technology:
(Date:1/27/2016)... Jan. 27, 2016  Rite Track, Inc. a leading ... West Chester, Ohio announced today the ... staff, based in Austin, Texas , ... to provide modifications, installations and technical support offerings for ... of PLUS, commented, "PLUS has provided world class service ...
(Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
Breaking Biology News(10 mins):